Clinical Trials Directory

Trials / Sponsors / VBI Vaccines Inc.

VBI Vaccines Inc.

Industry · 11 registered clinical trials2 currently recruiting.

StatusTrialPhaseStarted
RecruitingPREHEVBRIO Pregnancy Outcomes Registry
Vaccine Exposure During Pregnancy
2023-11-30
WithdrawnSafety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuv
COVID-19, Coronavirus Infections
Phase 12023-03-01
UnknownSafety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a
COVID-19, Coronavirus Infections
Phase 12022-10-05
CompletedSafety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a
Covid19
Phase 12021-03-15
CompletedLot-to-lot Consistency of Sci-B-Vac™ in Adults
Hepatitis B Vaccines
Phase 32017-12-14
CompletedImmunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults
Hepatitis B Vaccines
Phase 32017-12-13
RecruitingStudy to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Su
Glioblastoma Multiforme
Phase 1 / Phase 22017-12-06
CompletedStudy to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healt
Cytomegalovirus Infections
Phase 12016-06-23
CompletedA Study to Qualify an In-house Reference Standard Batch of Sci-B-Vac™
Hepatitis B
Phase 42015-11-01
CompletedSafety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B®
Hepatitis B
Phase 32014-04-18
CompletedA Bridging Study: Comparing Two Lots of Sci-B-Vac™ and Engerix-B in Healthy Adults
Hepatitis B
Phase 32006-03-02